T. De Reijke

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel, Tim Muilwijk et autres

de, nl, fr, be, es, cz, tr, se (code pays fourni par la source)

Elderly prostate cancer patients in the Netherlands have a worse prognosis than younger patients: A population-based study

Robin W.M. Vernooij, Inge M. van Oort, T. De Reijke, K. Aben

Monopolar versus bipolar transurethral resection for primary non-muscle invasive bladder cancer

Esmee I.M.L. Liem, M. McCormack, Erica On-Ting Chan, Yohei Matsui et autres

Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial

M.J.S. Scheltema, Willemien van den Bos, Daniël M. de Bruin, Hessel Wijkstra et autres

Background: Current surgical and ablative treatment options for prostate cancer (PCa) may result in a high incidence of (temporary) incontinence, erectile dysfunction and/or bowel damage. These side effects are due to procedure related effects on adjacent structures including blood vessels, bowel, urethra …

Quality of cancer care in the Netherlands: Variation in treatment of prostate cancer

Katja K.H. Aben, Inge M. van Oort, Sabine Siesling, C. van de Velde et autres

17 IS THERE A ROLE FOR FOCAL THERAPY IN PROSTATE CANCER – NON-RADIATION TECHNIQUES?

T. De Reijke

264 speaker SURGERY

T. De Reijke

Long term results of immediate post-operative radiotherapy after radical prostatectomy in pT3N0 prostate cancer (EORTC 22911)

M. Bolla, Hendrik Van Poppel, Bertrand Tombal, K. Vekemans et autres

102 poster: PDR Brachytherapy Boost for Intermediate Risk Prostate Cancer, Dose Escalation With Limited Toxicity

Elisabeth D. Geijsen, L. Blank, H. van der Grient, Kees Koedooder et autres

Treatment approaches in patients with hormone resistant prostate cancer

T. De Reijke, Jean de la Rosette

IMPACT OF PATHOLOGICAL REVIEW OF RADICAL PROSTATECTOMY SPECIMENS ON PROGNOSIS AND PREDICTED BENEFIT FROM IMMEDIATE POSTOPERATIVE IRRADIATION FOR HIGH-RISK PATIENTS (EORTC 22911)

Theodorus van der Kwast, M. Bolla, Hendrik Van Poppel, K. Vekemans et autres

Does post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improve progression-free survival (PFS) in pT3N0 prostate cancer (PC)? (EORTC 22911)

M. Bolla, Hendrik Van Poppel, Paul Van Cangh, K. Vekemans et autres

4504 Background:In 1992, as radical prostatectomy was more frequently applied to clinical T1–2N0M0 prostate cancer, the EORTC has undertaken a randomized trial of immediate post-operative treatment versus wait-and-see policy, for patients with high risk factors of local relapse on pathological specimen. We …

nl, be (code pays fourni par la source)